Burlingame, CA, United States of America

Epitomics, Inc.


USPTO Granted Patents = 30

% Expired Patents = 6.7



Trademarks = 1

Forward Citations = 253

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Guo-Liang Yu (16 out of 142 patents)

silverMedal Yaohuang Ke (11 out of 16 patents)

bronzeMedal Weimin Zhu (9 out of 19 patents)

4.  Fernando Jose Rebelo Do Couto (7 out of 31 patents)

5.  Kristin Beth Hendricks (7 out of 8 patents)

6.  Robert Pytela (6 out of 15 patents)

7.  Qi Qian (6 out of 6 patents)

8.  Harry C Au (6 out of 6 patents)

9.  Stacey Ellen Wallace (5 out of 9 patents)

10.  Luc Adam (3 out of 26 patents)

11.  Karin Vroom (2 out of 2 patents)

12.  Mark Bushfield (2 out of 3 patents)

13.  Michael Hadjisavas (2 out of 2 patents)

14.  S Ellen Wallace (2 out of 3 patents)

15.  Liang Xiang (1 out of 1 patent)


Core Competencies:
Antibody Identification
Monoclonal Antibody
Lineage Analysis
Antibody Engineering
CDR-Anchored Amplification
TNFα-Neutralizing Antibodies
Anti-VEGF Antibody
B Cell Panning
FACS Method
Cell Fusion Method
Differentially Expressed Proteins
Fusion Partner

30 patents:

Epitomics, Inc., based in Burlingame, California, specializes in the development and manufacturing of innovative antibody products and related technologies. The company focuses on providing high-quality research tools for the life sciences sector, particularly in areas such as cancer research, immunology, and neuroscience. Epitomics is recognized for its expertise in custom antibody production and its commitment to advancing scientific discovery through reliable and effective solutions.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Epitomics, Inc.
30 Patents

#4 in Burlingame, CA

#2,677 in California

#11,257 in US

#21,853 in the World

Burlingame, CA (US)
Burlingame, CA, United States of America
Forward Citations = 253

17 inventors:

Please report any incorrect information to [email protected]
Loading…